Literature DB >> 12794262

Unusual manifestations of the antiphospholipid syndrome.

Ronald A Asherson1, Ricard Cervera.   

Abstract

The classical clinical picture of the antiphospholipid syndrome (APS) is characterized by venous and arterial thromboses, fetal losses and thrombocytopenia, in the presence of antiphospholipid antibodies (aPL), namely lupus anticoagulant (LA), anticardiolipin antibodies (aCL), or antibodies to the protein "cofactor" b2 glycoprotein I. Single vessel involvement or multiple vascular occlusions may give rise to a wide variety of presentations. Any combination of vascular occlusive events may occur in the same individual and the time interval between them also varies considerably from weeks to months or even years. Deep vein thrombosis, sometimes accompanied by pulmonary embolism, is the most frequently reported manifestation in this syndrome. Cerebrovascular accidents-either stroke or transient ischemic attacks-are the most common arterial thrombotic manifestations. Early and late fetal losses, premature births and pre-eclampsia are the most frequent fetal and obstetric manifestations. Additionally, several other clinical features are relatively common in these patients, i.e., thrombocytopenia, livedo reticularis, heart valve lesions, hemolytic anemia, epilepsy, myocardial infarction, leg ulcers, and amaurosis fugax. However, a large variety of other clinical manifestations have been less frequently described in patients with the APS, with prevalences lower than 5%. These include, among others, large peripheral or aortic artery occlusions, Sneddon's syndrome, chorea, transverse myelopathy, intracardiac thrombus, adult respiratory distress syndrome, renal thrombotic microangiopathy, Addison's syndrome, Budd-Chiari syndrome, nodular regenerative hyperplasia of the liver, avascular necrosis of the bone, cutaneous necrosis or subungual splinter hemorrhages. In this article, some of these "unusual" manifestations are reviewed.

Entities:  

Mesh:

Year:  2003        PMID: 12794262      PMCID: PMC7101991          DOI: 10.1385/CRIAI:25:1:61

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  208 in total

1.  LUPOID HEPATITIS.

Authors:  T B REYNOLDS; H A EDMONDSON; R L PETERS; A REDEKER
Journal:  Ann Intern Med       Date:  1964-10       Impact factor: 25.391

2.  The pulseless syndrome.

Authors:  M H LESSOF; L E GLYNN
Journal:  Lancet       Date:  1959-04-18       Impact factor: 79.321

3.  Progressive optic atrophy and the primary antiphospholipid antibody syndrome.

Authors:  S L Gerber; L B Cantor
Journal:  Am J Ophthalmol       Date:  1990-10-15       Impact factor: 5.258

4.  Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities.

Authors:  K Nagasawa; Y Ishii; T Mayumi; Y Tada; A Ueda; Y Yamauchi; T Kusaba; Y Niho
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

5.  Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus.

Authors:  A Montehermoso; R Cervera; J Font; M Ramos-Casals; M García-carrasco; F Formiga; J L Callejas; M Jorfán; M C Griñó; M Ingelmo
Journal:  Semin Arthritis Rheum       Date:  1999-04       Impact factor: 5.532

6.  Severe Guillain-Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients.

Authors:  G Frampton; J B Winer; J S Cameron; R A Hughes
Journal:  J Neuroimmunol       Date:  1988-08       Impact factor: 3.478

Review 7.  Acute transverse myelopathy complicating systemic lupus erythematosus.

Authors:  D J Propper; R C Bucknall
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

8.  Lupus nephritis: clinical and pathological correlation.

Authors:  B Leaker; K F Fairley; J Dowling; P Kincaid-Smith
Journal:  Q J Med       Date:  1987-02

9.  Antibody to cardiolipin causing hepatic infarction in a post partum patient with systemic lupus erythematosus.

Authors:  N Young; K P Wong
Journal:  Australas Radiol       Date:  1991-02

10.  Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.

Authors:  H I Glueck; K S Kant; M A Weiss; V E Pollak; M A Miller; M Coots
Journal:  Arch Intern Med       Date:  1985-08
View more
  11 in total

1.  Sudden sensorineural hearing loss in a patient with primary antiphospholipid syndrome.

Authors:  Levent Sinan Bir; Fatma Ozdemir Eşmeli; Fazil Necdet Ardiç
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

Review 2.  Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review.

Authors:  Priscila Mattos; Mittermayer B Santiago
Journal:  Clin Rheumatol       Date:  2011-01-05       Impact factor: 2.980

Review 3.  Liver involvement in patients with systemic autoimmune diseases.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2013-09

4.  Gastrointestinal manifestations in systemic autoimmune diseases.

Authors:  M Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Buchar)       Date:  2011-01

Review 5.  Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome.

Authors:  Roberta Gualtierotti; Martina Biggioggero; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 6.  Benign liver tumors in pediatric patients - Review with emphasis on imaging features.

Authors:  Liliana Chiorean; Xin-Wu Cui; Andrea Tannapfel; Doris Franke; Martin Stenzel; Wojciech Kosiak; Dagmar Schreiber-Dietrich; Jörg Jüngert; Jian-Min Chang; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

7.  Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome.

Authors:  Gabriela Cesarman-Maus; Nina P Ríos-Luna; Arunkumar B Deora; Bihui Huang; Rosario Villa; Maria del Carmen Cravioto; Donato Alarcón-Segovia; Jorge Sánchez-Guerrero; Katherine A Hajjar
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

8.  Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures.

Authors:  S Sangle; D P D'Cruz; M A Khamashta; G R V Hughes
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

9.  Antiphospholipid syndrome: a case report with an unusual wide spectrum of clinical manifestations.

Authors:  Carmela Mazzoccoli; Domenico Comitangelo; Alessia D'Introno; Valeria Mastropierro; Carlo Sabbà; Antonio Perrone
Journal:  Auto Immun Highlights       Date:  2019-10-19

Review 10.  Antiphospholipid syndrome.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Arthritis Res Ther       Date:  2008-12-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.